Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2009
Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models
J S Vermaat, I van der Tweel, N Mehra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2024
Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma
N Agarwal, J Brugarolas, P Ghatalia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 3, 2025
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial
L Bergmann, L Albiges, M Ahrens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 5, 2021
<sup>89</sup>Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer
I C Kok, J S Hooiveld, P P van de Donk, et al.
British Journal of Cancer
|
April 28, 2025
Rechallenge of ipilimumab and nivolumab in advanced melanoma patients after previous ipilimumab-based therapy
E J van Dijk, H H Nienhuis, A J M van den Eertwegh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 5, 2024
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry
A Özkan, E Kapiteijn, F van den Bos, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2009
Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models
J S Vermaat, I van der Tweel, N Mehra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2024
Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma
N Agarwal, J Brugarolas, P Ghatalia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 3, 2025
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial
L Bergmann, L Albiges, M Ahrens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 5, 2021
<sup>89</sup>Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer
I C Kok, J S Hooiveld, P P van de Donk, et al.
British Journal of Cancer
|
April 28, 2025
Rechallenge of ipilimumab and nivolumab in advanced melanoma patients after previous ipilimumab-based therapy
E J van Dijk, H H Nienhuis, A J M van den Eertwegh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 5, 2024
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry
A Özkan, E Kapiteijn, F van den Bos, et al.
Page
of 3